Ignite Creation Date:
2025-12-25 @ 1:02 AM
Ignite Modification Date:
2026-01-05 @ 6:32 PM
Study NCT ID:
NCT06784193
Status:
RECRUITING
Last Update Posted:
2025-10-10
First Post:
2025-01-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
Sponsor:
Olema Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-12-16
Start Date Type:
ACTUAL
Primary Completion Date:
2027-05-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-08-30
Completion Date Type:
ESTIMATED
First Submit Date:
2025-01-14
First Submit QC Date:
None
Study First Post Date:
2025-01-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-08
Last Update Post Date:
2025-10-10
Last Update Post Date Type:
ESTIMATED